Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03950791 · ClinicalTrials.gov registry record · NA

Single Session Class to Reduce Opioid Use in Chronic Pain

A NA study of Chronic Pain, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
213
Enrollment target
1
Study location

NCT03950791 is a NA study of Chronic Pain that has completed, run by Stanford University. The registered enrollment target is 213 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03950791, a NA study of Chronic Pain, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
213 participants
Enrollment target
1
Study location

Study Summary

Prescription opioids are one of the most commonly used treatments for chronic pain, despite limited evidence of their efficacy and high morbidity and mortality risks. The study aims to determine the efficacy of a targeted single-session psychology class in reducing opioid use among patients with chronic pain. The information gained from this study has the potential to identify patients who achieve a meaningful reduction in opioid use and inform opioid reduction strategies.

Conditions Studied

Interventions

  • BEHAVIORAL Health Education
  • BEHAVIORAL Pain Catastrophizing Class

Study Locations (1)

California

  • Stanford University - Palo Alto

Trial Details

FieldValue
Enrollment Target 213 participants
Start Date 2019-09-23
Est. Completion 2024-05-31
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT03950791

The ClinicalTrials.gov registry entry for NCT03950791 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 213 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (72% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Health Education is the first listed.

NCT03950791 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03950791 about?

NCT03950791 is a clinical study titled "Single Session Class to Reduce Opioid Use in Chronic Pain". Prescription opioids are one of the most commonly used treatments for chronic pain, despite limited evidence of their efficacy and high morbidity and mortality risks. The study aims to determine the efficacy of a targeted single-session psychology class in reducing opioid use among patients with chr...

What is the current status of trial NCT03950791?

This trial is currently completed. It is a NA study. The enrollment target is 213 participants. The study started on 2019-09-23. Estimated completion is 2024-05-31.

What conditions does trial NCT03950791 study?

This clinical trial studies the following conditions: Chronic Pain.

What interventions are being tested in trial NCT03950791?

The interventions under investigation include: Health Education (BEHAVIORAL), Pain Catastrophizing Class (BEHAVIORAL).

Who is sponsoring clinical trial NCT03950791?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03950791 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.